| 000 | 01733 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516072943.0 | ||
| 264 | 0 | _c20120305 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/j.1365-2249.2011.04517.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarr, L A | |
| 245 | 0 | 0 |
_aImmunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cFeb 2012 |
||
| 300 |
_a216-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunologic Surveillance |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 | _aT-Cell Antigen Receptor Specificity |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aTransduction, Genetic |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 | _aTumor Escape |
| 650 | 0 | 4 |
_aTumor Microenvironment _ximmunology |
| 700 | 1 | _aGilham, D E | |
| 700 | 1 | _aCampbell, J D M | |
| 700 | 1 | _aFraser, A R | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 167 _gno. 2 _gp. 216-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2011.04517.x _zAvailable from publisher's website |
| 999 |
_c21452629 _d21452629 |
||